Clinical trial
A Single Blinded Study on the Effect of Saccharomyces Boulardii CNCM I-745 on Growth and Development in Preterm Infants
NCT02310425 is registered in ClinicalTrials.gov with Lingfen Xu, MD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Single Blinded Study on the Effect of Saccharomyces Boulardii CNCM I-745 on Growth and Development in Preterm Infants
- Lead sponsor
- Lingfen Xu, MD
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- March 31, 2013
- Completion date
- January 31, 2014
- Enrollment
- 125 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.